Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selection of precore mutants during lamivudine treatment in patients with chronic hepatitis B.

Hepato-gastroenterology - 1 Jan 2000

Cheong Jae Youn, Cho Sung Won, Yoo Jun Hwan, Hong Sun Pyo, Kim Soo-Ok, Yoo Wang Don, Kim Jin Hong

Abstract excerpt

BACKGROUND/AIMS: Evolution of precore genes can occur during lamivudine therapy in HBV infection. This study investigated the changes in precore regions in patients treated with lamivudine and the pattern during relapse. METHODOLOGY: The sequences of codon 28 in precore region in serial samples of 16 patients with HBV (11 HBeAg-positive and 5 HBeAg-negative) treated with lamivudine were analyzed by restriction...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Antibodies
Share to Hepatitis B, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B Core Antigens

Share to Hepatitis B e Antigens

Share to Hepatitis B virus

Share to Lamivudine

Share to Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Source

Identifiers

PMID: 18705323

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selection of precore mutants during lamivudine treatment in patients with chronic hepatitis B.PMID 18705323Read ↗

Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy.Semantic proximity Read ↗

Changes in different regions of hepatitis B virus gene in hepatitis B 'e' antigen-negative patients with chronic hepatitis B: the effect of long-term lamivudine therapy.Semantic proximity Read ↗

Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.Semantic proximity Read ↗

Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion.Semantic proximity Read ↗

Hepatitis B virus precore mutants in HBeAg carriers with chronic hepatitis treated with interferon.Semantic proximity Read ↗

Lamivudine resistance in patients with chronic hepatitis B: Role of clinical and virological factorsSemantic proximity Read ↗

Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy.Semantic proximity Read ↗

Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.Semantic proximity Read ↗

Genotype prevalence, viral load and outcome of hepatitis B virus precore mutant infection in stable patients and in patients after liver transplantation.Semantic proximity Read ↗

Predictive value of precore hepatitis B virus mutations in spontaneous and interferon-induced hepatitis B e antigen clearance.Semantic proximity Read ↗

Selection of a precore mutant of hepatitis B virus and reactivation of chronic hepatitis B acquired in childhood.Semantic proximity Read ↗

Low prevalence of precore mutations in hepatitis B virus DNA in fulminant hepatitis type B in France.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.